Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (email@example.com).
Goto M, Chiba J, Matsuura M, Iwaki-Egawa S, Watanabe Y.
Aging-associated latent herpes viral infection in normal Japanese individuals and patients with Werner syndrome.Intractable Rare Dis Res
PubMed ID: 30560014
Makoto Goto, Junji Chiba, Masaaki Matsuura, Sachiko Iwaki-Egawa, Yasuhiro Watanabe
Inflammageing assessed by MMP9 in normal Japanese individuals and the patients with Werner syndromeIntractable Rare Dis Res
PubMed ID: 27195193
Sadahira Y, Sugihara T, Fujiwara H, Nishimura H, Suetsugu Y, Takeshita M, Okamura S, Goto M.
WRN protein as a novel erythroblast immunohistochemical marker with applications for the diagnosis of Werner syndromeVirchows Arch
PubMed ID: 25503078
M Goto, Y Ishikawa, M Sugimoto, Y Furuichi
Werner syndrome: a changing pattern of clinical manifestations in Japan (1917~2008)Biosci Trends
PubMed ID: 23524889
M Goto, S Iwaki-Egawa, Y Watanabe
Ageing in Werner syndromeBiosci Trends
PubMed ID: 22426101